Int Med Case Rep J. 2009 Mar 19;2:11-3. doi: 10.2147/imcrj.s5254. Print 2009.

Myopathy following postoperative ablative radioiodine for follicular carcinoma of the thyroid.

International medical case reports journal

Hermione C Price, Vijay Jayagopal

PMID: 23754875 PMCID: PMC3658207 DOI: 10.2147/imcrj.s5254

Abstract

We highlight a case of disabling myopathy following radioablative iodine treatment for follicular carcinoma of the thyroid. A 34-year-old man presented with a tender neck swelling, ultrasound and biopsy were suggestive of thyroid malignancy. Thyroidectomy was undertaken and histology confirmed follicular carcinoma of the thyroid. Treatment with ablative radioiodine followed and within days the patient developed disabling myopathy. Investigations to date do not reveal any other cause for the myopathy and there is no evidence to suggest that this is a paraneoplastic phenomenon. We believe this is the first reported case of ablative radioiodine-induced mypoathy.

Keywords: iodine radioisotopes; muscular diseases; thyroid neoplasms

References

1. Ann Nucl Med. 2007 Aug;21(6):367-9 - PubMed
2. Curr Opin Neurol. 1998 Dec;11(6):627-32 - PubMed
3. Scand J Public Health. 2002;30(4):281-7 - PubMed
4. Kaohsiung J Med Sci. 2000 Feb;16(2):68-75 - PubMed
5. Lancet. 2003 Feb 8;361(9356):501-11 - PubMed
6. Arch Phys Med Rehabil. 1995 Jul;76(7):685-7 - PubMed
7. Lancet. 2000 Aug 19;356(9230):614 - PubMed
8. J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):750-5 - PubMed
9. Clin Nucl Med. 1996 Oct;21(10):780-2 - PubMed

Publication Types

• Case Reports